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BY-NC-ND license (http://creativecomAbstract The aim of this study was to investigate the dose-dependent effect of ghrelin on
gastric emptying in rats and the related mechanism of action. Sixty Wistar rats were random-
ized into control and test groups, which respectively received intraperitoneal injection of
normal saline and ghrelin at different doses (0.5 nmol/kg, 1.0 nmol/kg, 1.5 nmol/kg,
2.0 nmol/kg, and 2.5 nmol/kg). After 45 minutes, all rats were gavaged with semisolid paste.
The gastric emptying rate was determined 30 minutes later, and the plasma cholecystokinin
level was tested by radioimmunoassay. The mean gastric emptying rate in the test groups
was significantly higher than in the control group (38.24  7.15% and 27.18  2.37%, respec-
tively, p < 0.05). Medium and high doses of ghrelin (1.0 nmol/kg, 1.5 nmol/kg, 2.0 nmol/kg,
and 2.5 nmol/kg), but not low dose (0.5 nmol/kg), accelerated the gastric emptying. In addi-
tion, the plasma cholecystokinin level in the test groups was significantly higher than in the
control group (p < 0.01). The gastric emptying rate was positively correlated with the plasma
cholecystokinin level (p < 0.01). Intraperitoneal injection of ghrelin at medium and high doses
significantly accelerated gastric emptying in rats.
Copyright ª 2016, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. This is an
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Ghrelin, a newly discovered 28 amino acid endogenous
peptide, is an endogenous ligand of growth hormone
secretagogue receptor (GHSR), which induces extensive
biological effects after binding to GHSR. Ghrelin promotes
secretion of growth hormone, enhances appetite, lowers
fat utilization, increases body weight, maintains a positive
energy balance, and regulates energy metabolism [1].y Elsevier Taiwan LLC. This is an open access article under the CC
).
Table 1 Comparison of gastric emptying between two
groups.
Groups Cases Gastric emptying rate (%)
Control 10 27.03  2.91
Test 50 38.24  7.15*
* Compared with control group, p Z 0.0000415.
114 S.-G. Cao et al.Ghrelin is produced mainly by gastric endocrine cells and
enters the blood circulation. Gastric electrophysiological
stimulation can markedly promote gastric endocrine cells
to produce ghrelin [2]. Research has shown that ghrelin can
accelerate gastric emptying and small intestinal propulsion
in Suncus murinus and mice [3,4]. High doses of ghrelin can
significantly enhance contraction of gastrointestinal
smooth muscle [5], and intraventricular or intravenous in-
jection of ghrelin can induce postprandial rapid gastric and
duodenal contractions in control rats [6]. However, there
are few data on the role of ghrelin in the regulation of
gastric emptying. We aimed to observe the effects of
intraperitoneally injected ghrelin at different doses on
gastric emptying in rats to illuminate the regulatory effect
of ghrelin on gastric emptying, and to simultaneously
detect plasma cholecystokinin level, so as to explore the
mechanism of ghrelin in the regulation of gastric emptying.
Methods
Animals and grouping
A total of 60 healthy male Wistar rats weighing 200e250 g
were provided by Laboratory Animal Centre of Wenzhou
Medical University. This study was carried out in strict
accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National In-
stitutes of Health. The animal use protocol has been
reviewed and approved by the Institutional Animal Care and
Use Committee of Wenzhou Medical University.
Rats were maintained under a diurnal cycle at 22  3C
with free access to food and water. After 1 week of adap-
tive raising, the rats were deprived of food for 24 hours and
of water for 12 hours, and then randomized into control and
test (AeE) groups with 10 rats in each group. The rats in the
control and test groups received intraperitoneal injection
of normal saline (1 mL) and ghrelin (Sigma, St. Louis, MO,
USA) at different doses (A, 0.5 nmol/kg; B, 1.0 nmol/kg; C,
1.5 nmol/kg; D, 2.0 nmol/kg; and E, 2.5 nmol/kg).
Semisolid paste preparation
Five grams of hydroxymethyl cellulose was dissolved in
125 mL distilled water and the following ingredients were
added and mixed to make 150 mL semisolid paste (150 g):
8 g milk powder, 4 g sugar, and 4 g starch [7]. The prepa-
ration was stored in the fridge for 12 hours and kept at
room temperature for 2 hours before use.
Gastric emptying test
The rats in the control group and test groups AeE received
intraperitoneal injection of normal saline (1 mL) and
0.5 nmol/kg, 1.0 nmol/kg, 1.5 nmol/kg, 2.0 nmol/kg, and
2.5 nmol/kg octanoyl ghrelin, respectively. Each rat was
gavaged with 1 mL semisolid paste after 45 minutes. The
tail venous blood was collected 30 minutes later under
anesthesia with intraperitoneal injection of pentobarbital
(the anesthetic dose of phenobarbital was 8 mg/kg). The
abdominal cavity was opened, and the pylorus and cardiawere ligated. The stomach was taken out and weighed after
being dried with filter paper. It was then cut along the
greater curvature, and the gastric content was washed off;
the net weight of the stomach was recorded after drying.
The difference between the stomach full weight and net
weight was defined as the stomach residue weight; the
gastric residual rate was the percentage of stomach residue
in semisolid paste; the gastric emptying rate was calculated
using the following formula:gastric emptying rateZ½1
 ðstomach full weight net weightÞ  100%: ð1Þ
At the end of the experiments measuring gastric
emptying, animals were euthanized by intraperitoneal in-
jection of excess doses of pentobarbital (the anesthetic
dosage of phenobarbital was 40 mg/kg, with the concen-
tration as 2%). After intraperitoneal injection of a large
dose of phenobarbital, the rats stopped breathing and their
hearts stopped beating, so they were judged as dead.Detection of cholecystokinin level
The tail venous blood was collected into a tube with 0.3 mL
EDTA and 1000 kU aprotinin, followed by cryogenic centri-
fugation at 3000 g for 10 minutes. The plasma was isolated
and the cholecystokinin level was determined using a
radioimmunoassay kit (Beijing Haikerui Biotech Center,
Beijing, China).Statistical analysis
All results are presented as mean  standard error of the
mean. The effect of ghrelin on cholecystokinin level in
plasma was analyzed by one-way analysis of variance fol-
lowed by Dunnett’s post hoc testing. A p value < 0.05 was
considered statistically significant. Linear regression was
used to study the correlation.Results
Comparison of gastric emptying
After intraperitoneal injection of ghrelin, the gastric
emptying rate in the test groups (38.24  7.15%) was
significantly higher than that in the control group
(27.18  2.37%; pZ 4.15105; Table 1).
Table 3 Effects of ghrelin on plasma cholecystokinin level
in rats.
Groups Ghrelin dose
(nmol/kg)
Cases Cholecystokinin
(ng/L)
p*
Control 10 44.17  5.18
A 0.5 10 48.37  4.95 0.04
B 1.0 10 52.74  5.3 0.0009
C 1.5 10 57.86  4.27 2.3  106
D 2.0 10 61.47  5.87 7.97  107
E 2.5 10 66.73  4.74 3.5  109
* Compared with control group.
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gastric emptying
The small dose of ghrelin (0.5 nmol/kg) did not accelerate
gastric emptying compared to the control group. Medium
and high doses of ghrelin gradually increased gastric
emptying rates; the emptying rates were significantly
greater than in the control group (Table 2).
Cholecystokinin level
After intraperitoneal injection of ghrelin at increasing
doses (0.5 nmol/kg, 1.0 nmol/kg, 1.5 nmol/kg, 2.0 nmol/
kg, and 2.5 nmol/kg), plasma cholecystokinin level was
elevated (44.17  5.18 ng/L, 48.37  4.95 ng/L,
52.74  5.3 ng/L, 57.86  4.27 ng/L, and 61.47  5.87 ng/
L, respectively), to levels significantly higher than in the
control group (Table 3).
Correlation analysis
Intraperitoneal injection of ghrelin at different doses
accelerated gastric emptying of healthy male Wistar rats.
With increasing dose of ghrelin, there is a trend that gastric
emptying accelerates. In addition, intraperitoneal injection
of ghrelin influenced rat plasma cholecystokinin level. The
gastric emptying rate in rats was positively correlated with
plasma cholecystokinin level (r Z 0.708, p < 0.01), indi-
cating that cholecystokinin might be involved in the regu-
lation of gastric emptying by ghrelin (Figure 1).
Discussion
Ghrelin, consisting of 28 amino acids, is a newly discovered
endogenous peptide secreted by fundic X/A-like cells, and
is the endogenous ligand of GHSR. Increasing electrophysi-
ological stimulation of the rat stomach can lead to the
enhancement of ghrelin production by gastric endocrine
cells [2], which then binds with GHSR, resulting in extensive
biological effects, for example, the promotion of growth
hormone release and adjustment of energy metabolism.
Ghrelin receptor belongs to the G-protein-coupled family.Table 2 Doseeeffect relationship between ghrelin and
gastric emptying in rats.a
Groups Ghrelin dose (nmol/
kg)
Cases Gastric emptying rate
(%)
Control 10 27.03  2.91
A 0.5 10 29.78  4.68
B 1.0 10 34.59  4.07#
C 1.5 10 38.33  4.41#
D 2.0 10 41.88  3.94#
E 2.5 10 46.64  4.14#
# Compared with the control group, the difference was statis-
tically significant.
a Compared with control group, (A) p Z 0.066, (B)
pZ 7.6  105, (C) pZ 1.2  106, (D) pZ 1.6  109, and (E)
p Z 1.8  1010.The structural similarity of the peptide has stimulated in-
terest in the relationship between ghrelin and gastric
emptying or intestinal motility.
In our research, ghrelin was found to accelerate gastric
emptying in rats, and to some degree, it was a doseeeffect
relationship. Gastric emptying increased after intraperito-
neal injection of low-dose ghrelin compared with the con-
trol group but the difference was not significant. However,
intermediate and large doses of ghrelin promoted gradual
gastric emptying. By contrast, intraperitoneally injected
ghrelin at all doses increased cholecystokinin level in rat
plasma, which correlated to some extent with the gastric
emptying rate.
It has been proven in rat and mouse studies that ghrelin
and ghrelin agonist (growth hormone releasing peptide-6)
accelerated gastric emptying [8,9], and that ghrelin also
promoted gastric emptying in a rat model with postoperative
obstruction [10]. In human studies, ghrelin was found to
accelerate gastric emptying in healthy controls [4] and in
patients with idiopathic or diabetic gastroparesis [11,12].
Endogenous ghrelin can modulate the Phase III-like
contraction that appears in the rat or mouse stomach [6],
induce the earlier Phase III of Migrating Motor Complex
(MMC) of the stomach and the duodenum, and enhance
contraction in Phase III of MMC. Continuous intravenous
infusion of ghrelin to patients following open colectomy
could increase the speed of gastric emptying during infusion,
improve the recovery of intestinal tract function, shorten
the anal exhaust time, and affect the release of certain
gastrointestinal hormones, thereby indicating that the ef-
fect of ghrelin on gastrointestinal motility works through
humoral factors [13]. The ghrelin agonist TZP-101 signifi-
cantly alleviates nausea and vomiting in patient with gas-
troparesis [14]. Recent studies have indicated that a daily
dose of 10e40 mg TZP-102 improved the symptoms of dia-
betic gastroparesis. However, there was no correlation be-
tween symptom improvement and gastric emptying change
in diabetic gastroparesis [15]. Oral or intraperitoneal injec-
tion of levodopa significantly inhibits the gastric emptying of
healthy rats, while ghrelin clearly reverses such inhibition
[16]. Our research was consistent with these results, indi-
cating that ghrelin could accelerate gastric emptying.
However, some studies have yielded different results: one
study indicated that intravenous injected ghrelin had no
significant effect on gastrointestinal movement in dogs in
fasting and postprandial conditions, while large doses of
intravenous injected ghrelin significantly reduced the
Figure 1. Correlation analysis of gastric emptying rats with plasma cholecystokinin level.
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gastric emptying [17]. These differences may reflect the
different clinical implications between intravenous and
intraperitoneal injection. Different molecular forms of
ghrelin have demonstrated different effects on gastric
emptying. Symplectic acylated ghrelin enhanced rat gastric
emptying, while deacylated ghrelin applied intra-
cerebroventricularly inhibited rat gastric emptying following
intake of a semifluid diet [18]. In another study, it was
demonstrated that the effect of ghrelin on gastric emptying
could also be affected by the form and composition of
gastric content. Peripheral intravenous ghrelin administra-
tion could promote gastric emptying of non-nutritive liquid
material, but not of nutritive liquid material.
Cholecystokinin, which exists extensively in many parts
of the human body and is one of the most studied gastro-
intestinal hormones, is a kind of brain-gut peptide with
wide ranging biological activities which not only stimulate
gallbladder contraction, but also play an important role in
the regulation of overall gastrointestinal movement.
Cholecystokinin can inhibit the gastric emptying of solids
and liquids by means of relaxing the proximal stomach,
increasing the pyloric sphincter tension, and altering the
gastric emptying pattern [19,20]. Although many studies
support the view that cholecystokinin inhibits gastric
emptying physiologically, due to the complexity of gastric
emptying regulation and gastric motility, the exact role of
cholecystokinin within this process is still uncertain. Ghre-
lin can promote the release of gastrointestinal hormones,
such as cholecystokinin, glucagon-like peptide 1 (GLP-1),
and nitric oxide (NO) [21]. Some researchers have indicated
that gastric emptying of high-fat diet-induced obese rats
was positively correlated with plasma ghrelin level, andnegatively associated with plasma cholecystokinin and
leptin level [4]. However, in our research, the rat plasma
cholecystokinin concentration and the gastric emptying
speed increased after intraperitoneal injection of ghrelin,
and the plasma cholecystokinin concentration was posi-
tively correlated with the gastric emptying rate, which is
opposite to the above-mentioned results. In our study, the
increasing cholescystokinn level after ghrelin injection was
confirmed, and the plasma cholecystokinin concentration
was positively correlated with the gastric emptying rate.
We supposed that the high level of cholecystokinin could be
increased the effect of gastric emptying through diastolic
proximal stomach and improve the tension of pyloric
sphincter. Furthermore, the high level cholecystokinin
could increase the excitatory effect on the function of the
small and large intestines, causing small intestine and colon
movement. Whether cholecystokinin plays a role in the
gastric emptying regulation of ghrelin is still to be
confirmed.
In conclusion, intraperitoneal ghrelin injection can
accelerate gastric emptying. However, the pathophysio-
logical mechanism by which ghrelin affects gastric
emptying requires further investigation.References
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